Identification the M6a Regulator Mediated RNA Methylation Modification Patterns and Immune- Related Key Genes Involved in Ischaemic Stroke

Peng-Fei Zheng,Cheng-Cheng Huang,Ting Zhou,Hong-Wei Pan,Li-Zhong Huang,Chang-Lu Wang,Jing-Jing Rong

DOI: https://doi.org/10.21203/rs.3.rs-4498674/v1

2024-01-01

Abstract:Background The precise impact of RNA N6-methyladenosine (m6A) modification on the immune microenvironment in ischemic stroke (IS) remains unclear. This study aimed to investigate the influence of m6A modification on the immune microenvironment in IS and identify crucial immune-related genes associated with IS. Methods The RNA modification patterns among 108 IS samples were determined by examining the differential m6A regulators between samples from individuals with IS and normal samples. Single-sample gene-set enrichment analysis (ssGSEA) and gene set variation analysis (GSVA) were employed to estimate the abundance of specific infiltrating immune cells and assess 50 HALLMARK pathways between healthy subjects and IS patients, as well as among the distinct m6A modification patterns. The weighted gene co-expression network analysis (WGCNA) was utilized to identify meaningful modules associated with immune cells. Two machine learning methods were applied to identify the key immune-related genes associated with IS. Finally, meta-analysis based on six different datasets was employed to validate the expression levels of the identified key genes. Results A total of eight key differential m6A regulators were identified between healthy individuals and patients with IS using a random forest classifier. Based on the expression profiles of these eight m6A regulators, two distinct RNA modification patterns (m6A cluster-A and cluster-B) were observed among the IS samples. Differential abundance of infiltrating immune cells and activation of HALLMARK signalling pathways were identified between the normal and IS samples, as well as among the two distinct m6A modification patterns. Notably, the WGCNA method highlighted the significant association of the black module with m6A cluster-B and several infiltrating immune cells. Furthermore, two machine learning methods identified several key genes exhibiting differential expression between control subjects and IS patients, as well as among distinct m6A modification patterns, including ABCA1, CPD, PRRG4, WDR46, and C19orf24. Meta-analysis revealed an association between WDR46 and a decreased risk of IS, while CPD and ABCA1 were linked to an increased risk of IS. Conclusions The present study provides compelling evidence highlighting the pivotal role of m6A modification in shaping the intricate and diverse immune microenvironment of IS. Notably, the CPD, ABCA1 and WDR46 genes emerge as potential novel biomarkers with implications for accurate diagnosis and immunotherapy of IS. These discoveries deepen our understanding of the intricate interplay between m6A modification, immune responses, and the pathogenesis of IS, opening new avenues for personalized treatment approaches.